Tevogen Bio Holdings (FRA:G28) LT-Debt-to-Total-Asset : 0.01 (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Tevogen Bio Holdings LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Tevogen Bio Holdings's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.01.

Tevogen Bio Holdings's long-term debt to total assets ratio increased from Sep. 2023 (0.00) to Sep. 2024 (0.01). It may suggest that Tevogen Bio Holdings is progressively becoming more dependent on debt to grow their business.

Tevogen Bio Holdings LT-Debt-to-Total-Asset Historical Data

The historical data trend for Tevogen Bio Holdings's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tevogen Bio Holdings LT-Debt-to-Total-Asset Chart

Tevogen Bio Holdings Annual Data

Trend

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

3.07

Tevogen Bio Holdings Quarterly Data
	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial					-	-	0.05	0.03	0.01

Tevogen Bio Holdings LT-Debt-to-Total-Asset Calculation

Tevogen Bio Holdings's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	0	/	15.623
	=

Tevogen Bio Holdings's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )	/	Total Assets (Q: Sep. 2024 )
	=	0.039	/	3.864
	=

Tevogen Bio Holdings (FRA:G28) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Tevogen Bio Holdings LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Tevogen Bio Holdings's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Tevogen Bio Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tevogen Bio Holdings Inc (FRA:G28) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

TVGN:USA G28:Germany

Address

15 Independence Boulevard, Warren, NJ, USA, 07059

Website

https://www.tevogen.com

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Tevogen Bio Holdings Headlines

No Headlines